Sylvain Mareschal

Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study

Sydney Dubois, Pierre‐Julien Viailly, Sylvain Mareschal et al. · Clinical Cancer Research · 2016 · 196 citations · Full text

Medicine, Hematology, Oncology +17

Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma

Anne‐Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal et al. · Clinical Cancer Research · 2016 · 186 citations

Medicine, Hematology, Oncology +17

Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Hélène Lanic, Jérôme Kraut-Tauzia, Romain Modzelewski et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 155 citations

Medicine, Geriatric Medicine, Oncology +17

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases

Sydney Dubois, Pierre‐Julien Viailly, Élodie Bohers et al. · Clinical Cancer Research · 2016 · 128 citations

Medicine, Genetics, Molecular Genetics +17

Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma

Vincent Camus, Aspasia Stamatoullas, Sylvain Mareschal et al. · Haematologica · 2016 · 118 citations · Full text

Medicine, Hematology, Oncology +17